Das Arzneimittelsparpaket: Wie kann sich die Pharmaindustrie auf die neuen Rahmenbedingungen einstellen?

Pharma IQ

In this Pharma IQ podcast, Isabel Henkel, Director, Access & Reimbursement at Johnson & Johnson Medical, talks about how the pharma industry needs to adjust to the new requirements of the German government’s pharmaceutical savings programme (Arzneitmittelsparpaket), the future of market access, and whether Germany’s stance as leading pharma market is in danger as a result of the government’s plans. [inlinead]  
To continue reading this story get free access